Management of pregnancy in patients with congenital heart disease

Progress in Cardiovascular Diseases

Volumn 53, Issue 4, 2011, Pages 305-311

  Harris, Ian S ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Birth defects; Congenital heart disease; Pregnancy

Indexed keywords

ANTIBIOTIC AGENT; HEPARIN; WARFARIN;

ANTIBIOTIC PROPHYLAXIS; ANTICOAGULANT THERAPY; AORTA COARCTATION; AORTA DISEASE; AORTA STENOSIS; ARTICLE; CARDIOVASCULAR RESPONSE; CLINICAL ASSESSMENT; CONGENITAL HEART DISEASE; CYANOTIC HEART DISEASE; DRUG EFFICACY; DRUG SAFETY; DRUG SUBSTITUTION; DRUG WITHDRAWAL; EMBRYOTOXICITY; ENDOCARDITIS; FALLOT TETRALOGY; FETUS ECHOGRAPHY; FETUS RISK; FIRST TRIMESTER PREGNANCY; FONTAN PROCEDURE; HEART ATRIUM SEPTUM DEFECT; HEART HEMODYNAMICS; HEART VENTRICLE SEPTUM DEFECT; HIGH RISK PREGNANCY; HUMAN; LABOR; LOW DRUG DOSE; MATERNAL CARE; MATERNAL MORTALITY; PATIENT COUNSELING; PREGNANCY; PREGNANCY COMPLICATION; PREGNANCY DISORDER; PUERPERIUM; PULMONARY ARTERY STENOSIS; RISK ASSESSMENT; SECOND TRIMESTER PREGNANCY; THIRD TRIMESTER PREGNANCY; THROMBOSIS; TRICUSPID VALVE ATRESIA;

ADAPTATION, PHYSIOLOGICAL; ADULT; BLOOD VOLUME; CARDIAC OUTPUT; COUNSELING; FEMALE; FONTAN PROCEDURE; HEART DEFECTS, CONGENITAL; HEART SEPTAL DEFECTS; HEART VALVE DISEASES; HEMODYNAMICS; HUMANS; LABOR, OBSTETRIC; LOEYS-DIETZ SYNDROME; MARFAN SYNDROME; PREGNANCY; PREGNANCY COMPLICATIONS, CARDIOVASCULAR; PREGNANCY OUTCOME; PREGNANCY TRIMESTER, FIRST; PREGNANCY TRIMESTER, SECOND; PREGNANCY TRIMESTER, THIRD; SURVIVORS; ULTRASONOGRAPHY, PRENATAL; VASCULAR RESISTANCE;

EID: 79551496890     PISSN: 00330620     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pcad.2010.08.001     Document Type: Article

References (47)

1. Hoffman J.I., Kaplan S. The incidence of congenital heart disease. J Am Coll Cardiol 2002, 39:1890-1900.
2. Hoffman J.I., Kaplan S., Liberthson R.R. Prevalence of congenital heart disease. Am Heart J 2004, 147:425-439.
3. Cardiac disease in pregnancy. ACOG technical bulletin number 168-June 1992. Int J Gynaecol Obstet 1993, 41:298-306.
4. Chapman A.B., Abraham W.T., Zamudio S., et al. Temporal relationships between hormonal and hemodynamic changes in early human pregnancy. Kidney Int 1998, 54:2056-2063.
5. Fujitani S., Baldisseri M.R. Hemodynamic assessment in a pregnant and peripartum patient. Crit Care Med 2005, 33(10 Suppl):S354-S361.
6. Clark S.L., Cotton D.B., Pivarnik J.M., et al. Position change and central hemodynamic profile during normal third-trimester pregnancy and post partum. Am J Obstet Gynecol 1991, 164:883-887.
7. Gerhardt M.A., Gunka V.B., Miller R.J. Hemodynamic stability during labor and delivery with continuous epidural infusion. J Am Osteopath Assoc 2006, 106:692-698.
8. Van de Velde M., Van Schoubroeck D., Jani J., et al. Combined spinal-epidural anesthesia for cesarean delivery: dose-dependent effects of hyperbaric bupivacaine on maternal hemodynamics. Anesth Analg 2006, 103:187-190. table of contents.
9. Capeless E.L., Clapp J.F. When do cardiovascular parameters return to their preconception values?. Am J Obstet Gynecol 1991, 165(4 Pt 1):883-886.
10. Siu S.C., Sermer M., Colman J.M., et al. Prospective multicenter study of pregnancy outcomes in women with heart disease. Circulation 2001, 104:515-521.
11. Bonow R.O., Carabello B.A., Chatterjee K., et al. 2008 Focused update incorporated into the ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1998 Guidelines for the Management of Patients With Valvular Heart Disease): endorsed by the Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. Circulation 2008, 118:e523-e661.
12. Szekely P., Turner R., Snaith L. Pregnancy and the changing pattern of rheumatic heart disease. Br Heart J 1973, 35:1293-1303. PMCID: 458797.
13. Uebing A., Arvanitis P., Li W., et al. Effect of pregnancy on clinical status and ventricular function in women with heart disease. Int J Cardiol 2010, 139:50-59.
14. Hoffman J.I. Incidence of congenital heart disease: II. Prenatal incidence. Pediatr Cardiol 1995, 16:155-165.
15. Meberg A., Otterstad J.E., Froland G., et al. Outcome of congenital heart defects-a population-based study. Acta Paediatr 2000, 89:1344-1351.
16. Saari-Kemppainen A., Karjalainen O., Ylostalo P., et al. Ultrasound screening and perinatal mortality: controlled trial of systematic one-stage screening in pregnancy. The Helsinki Ultrasound Trial. Lancet 1990, 336:387-391.
17. Sharony R., Fejgin M.D., Biron-Shental T., et al. Who should be offered fetal echocardiography? One center's experience with 3965 cases. Isr Med Assoc J 2009, 11:542-545.
18. Yap S.C., Drenthen W., Pieper P.G., et al. Risk of complications during pregnancy in women with congenital aortic stenosis. Int J Cardiol 2008, 126:240-246.
19. Tzemos N., Silversides C.K., Colman J.M., et al. Late cardiac outcomes after pregnancy in women with congenital aortic stenosis. Am Heart J 2009, 157:474-480.
20. Banning A.P., Pearson J.F., Hall R.J. Role of balloon dilatation of the aortic valve in pregnant patients with severe aortic stenosis. Br Heart J 1993, 70:544-545. PMCID: 1025387.
21. Myerson S.G., Mitchell A.R., Ormerod O.J., et al. What is the role of balloon dilatation for severe aortic stenosis during pregnancy?. J Heart Valve Dis 2005, 14:147-150.
22. Jackson M., Walsh K.P., Peart I., et al. Epidemiology of congenital heart disease in Merseyside -1979 to 1988. Cardiol Young 1996, 6:272-280.
23. Drenthen W., Pieper P.G., Roos-Hesselink J.W., et al. Non-cardiac complications during pregnancy in women with isolated congenital pulmonary valvar stenosis. Heart 2006, 92:1838-1843. PMCID: 1861275.
24. Deal K., Wooley C.F. Coarctation of the aorta and pregnancy. Ann Intern Med 1973, 78:706-710.
25. Task Force on the Management of Cardiovascular Diseases During Pregnancy of the European Society of Cardiology Expert consensus document on management of cardiovascular diseases during pregnancy. Eur Heart J 2003, 24:761-781.
26. Beauchesne L.M., Connolly H.M., Ammash N.M., et al. Coarctation of the aorta: outcome of pregnancy. J Am Coll Cardiol 2001, 38:1728-1733.
27. Yap S.C., Drenthen W., Meijboom F.J., et al. Comparison of pregnancy outcomes in women with repaired versus unrepaired atrial septal defect. BJOG 2009, 116:1593-1601.
28. Yap S.C., Drenthen W., Pieper P.G., et al. Pregnancy outcome in women with repaired versus unrepaired isolated ventricular septal defect. BJOG 2010, 117:683-689.
29. Yentis S.M., Steer P.J., Plaat F. Eisenmenger's syndrome in pregnancy: Maternal and fetal mortality in the 1990s. Br J Obstet Gynaecol 1998, 105:921-922.
30. Presbitero P., Somerville J., Stone S., et al. Pregnancy in cyanotic congenital heart disease. Outcome of mother and fetus. Circulation 1994, 89:2673-2676.
31. Apitz C., Webb G.D., Redington A.N. Tetralogy of Fallot. Lancet 2009, 374:1462-1471.
32. Veldtman G.R., Connolly H.M., Grogan M., et al. Outcomes of pregnancy in women with tetralogy of Fallot. J Am Coll Cardiol 2004, 44:174-180.
33. Drenthen W., Pieper P.G., Roos-Hesselink J.W., et al. Outcome of pregnancy in women with congenital heart disease: a literature review. J Am Coll Cardiol 2007, 49:2303-2311.
34. Gelson E., Gatzoulis M., Steer P.J., et al. Tetralogy of Fallot: Maternal and neonatal outcomes. BJOG 2008, 115:398-402.
35. Pedersen L.M., Pedersen T.A., Ravn H.B., et al. Outcomes of pregnancy in women with tetralogy of Fallot. Cardiol Young 2008, 18:423-429.
36. Khairy P., Ouyang D.W., Fernandes S.M., et al. Pregnancy outcomes in women with congenital heart disease. Circulation 2006, 113:517-524.
37. Drenthen W., Pieper P.G., van der Tuuk K., et al. Cardiac complications relating to pregnancy and recurrence of disease in the offspring of women with atrioventricular septal defects. Eur Heart J 2005, 26:2581-2587.
38. Ploeg M., Drenthen W., van Dijk A., et al. Successful pregnancy after an arterial switch procedure for complete transposition of the great arteries. BJOG 2006, 113:243-244.
39. Drenthen W., Pieper P.G., Roos-Hesselink J.W., et al. Fertility, pregnancy, and delivery after biventricular repair for pulmonary atresia with an intact ventricular septum. Am J Cardiol 2006, 98:259-261.
40. Canobbio M.M., Mair D.D., van der Velde M., et al. Pregnancy outcomes after the Fontan repair. J Am Coll Cardiol 1996, 28:763-767.
41. Lipscomb K.J., Smith J.C., Clarke B., et al. Outcome of pregnancy in women with Marfan's syndrome. Br J Obstet Gynaecol 1997, 104:201-206.
42. Rossiter J.P., Repke J.T., Morales A.J., et al. A prospective longitudinal evaluation of pregnancy in the Marfan syndrome. Am J Obstet Gynecol 1995, 173:1599-1606.
43. Gutman G., Baris H.N., Hirsch R., et al. Loeys-Dietz syndrome in pregnancy: a case description and report of a novel mutation. Fetal Diagn Ther 2009, 26:35-37.
44. Vitale N., De Feo M., De Santo L.S., et al. Dose-dependent fetal complications of warfarin in pregnant women with mechanical heart valves. J Am Coll Cardiol 1999, 33:1637-1641.
45. Salazar E., Izaguirre R., Verdejo J., et al. Failure of adjusted doses of subcutaneous heparin to prevent thromboembolic phenomena in pregnant patients with mechanical cardiac valve prostheses. J Am Coll Cardiol 1996, 27:1698-1703.
46. Hanania G. Management of anticoagulants during pregnancy. Heart 2001, 86:125-126. PMCID: 1729872.
47. Wilson W, Taubert KA, Gewitz M, et al: Prevention of infective endocarditis: guidelines from the American Heart Association: a guideline from the American Heart Association Rheumatic Fever, Endocarditis and Kawasaki Disease Committee, Council on Cardiovascular Disease in the Young, and the Council on Clinical Cardiology, Council on Cardiovascular Surgery and Anesthesia, and the Quality of Care and Outcomes Research Interdisciplinary Working Group. J Am Dent Assoc 2007;138:739-745, 47-60.